Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 2, 1998, Pages 319-329

  Robertson, Chris ^a   Robertson, A Gerald ^b   Hendry, Jolyon H ^c   Roberts, Stephen A ^c   Slevin, Nicholas J ^c   Duncan, William B ^d   MacDougall, R Hugh ^d   Kerr, Gillian R ^d   O'Sullivan, B ^e   Keane, Thomas J ^f  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Carcinoma of the larynx; Gap length; Linear quadratic model; Time effects

Indexed keywords

ARTICLE; CALCULATION; CANADA; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

CARCINOMA; DOSE FRACTIONATION; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0032518457     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00716-5     Document Type: Article

References (26)

1. 1. Barton, M. B.; Keane, T. J.; Gadalla, T.; Maki, E. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer. Radiother. Oncol. 23:137-143; 1992.
2. 2. Bentzen, S. M. Radiobiological considerations in the design of clinical trials. Radiother. Oncol. 32:1-11; 1994.
3. 3. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. (B) 34:187-202; 1972.
4. 4. Cox, D. R.; Snell, E. J. The analysis of binary data, 2nd ed. London: Chapman and Hall; 1990.
5. 5. Duncan, W.; MacDougall, R. H.; Kerr, G.; Downing, D. The adverse effects of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother. Oncol. 41:203-207; 1996.
6. 6. Fowler, J. F.; Chappell, R. Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy [letter]. Eur. J. Cancer 30A:719-721; 1994.
7. 7. Fowler, J. F.; Lindstrom, M. J. Loss of local control with prolongation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 23:457-467; 1992.
8. 8. Harrington, D. P.; Fleming, T. R. A class of rank test procedures for censored survival data. Biometrika 69:553-566; 1982.
9. 9. Hermann, T.; Jakubek, A.; Trott, K. R. The importance of the timing of a split in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther. Onkol. 170:545-549; 1994.
10. 10. Hendry, J. H.; Roberts, S. A.; Slevin, N. J.; Keane, T. J.; Barton, M. B.; Agren-Cronqvist, A. Influence of radiotherapy treatment time on control of laryngeal cancer: Comparisons between centers in Manchester, UK and Toronto, Canada. Radiother. Oncol. 31:14-22; 1994.
11. 11. Hendry, J. H.; Bentzen, S. M.; Dale, R. S.; Fowler, J. F.; Wheldon, T. E.; Jones, B.; Munro, A. J.; Slevin, N. J.; Robertson, A. G. A modeled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin. Oncol. 8:297-307; 1996.
12. 12. Kaplan, E. L.; Meier, P. Non-parametric estimation from incomplete samples. J. Am. Stat. Assoc. 53:457-481; 1958.
13. 13. Maciejewski, B.; Preuss-Bayer, G.; Trott, K. R. The influence of the number of fractions and of overall treatment time on local control and late complications rate in squamous cell carcinoma of the larynx. Int. J. Radiat. Oncol. Biol. Phys. 9:321-328; 1983.
14. 14. Maciejewski, B.; Taylor, J. M. G.; Withers, H. R. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx. Radiother. Oncol. 7:323-326; 1986.
15. 15. Maciejewski, B.; Withers, H. R.; Taylor, J. M. G.; Hliniak, A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 1. Tumor dose response and regeneration. Int. J. Radiat. Oncol. Biol. Phys. 16:831-843; 1989.
16. 16. McCullagh, P.; Nelder, J. A. Generalized linear models, 2nd ed. London. Chapman and Hall; 1983.
17. 17. Overgaard, J.; Hjelm-Hansen, M.; Johansen, L. V.; Andersen, A. P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 27:147-152; 1988.
18. 18. Rezvani, M.; Fowler, J. H.; Hopewell, J. W.; Alcock, C. J. Sensitivity of the human squamous cell carcinoma of the larynx to fractionated radiotherapy. Br. J. Radiol. 66:245-255; 1993.
19. 19. Roberts, S. A.; Hendry, J. H.; Brewster, A. E.; Slevin, N. J. The influence of radiotherapy treatment time on the control of laryngeal cancer: A direct analysis of data from two British Institute of Radiotherapy trials to calculate the lag period and the time factor. Br. J. Radiol. 67:790-794; 1994.
20. 20. Robertson, A. G.; Robertson, C.; Boyle, P.; Symonds, R. P.; Wheldon, T. E. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur. J. Cancer 29A:501-510; 1993.
21. 21. Sambrook, D. Clinical trial of a modified (split course) technique of X-ray therapy in malignant tumors. Clin. Radiat. 36:369-372; 1968.
22. 22. Slevin, N. J.; Hendry, J. H.; Roberts, S. A.; Agren-Cronqvist, A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother. Oncol. 24:215-220; 1992.
23. 23. Skladowski, K.; Law, M. G.; Maciejewski, B.; Steel, G. G. Planned and unplanned gaps in radiotherapy: The importance of gap position and gap duration. Radiother. Oncol. 30:109-120; 1994.
24. 24. S-Plus Version 3.3 Advanced Data Analysis Software. Seattle, WA: StatSci.; 1995.
25. 25. Taylor, J. M. C.; Withers, H. R. Influence of selection bias on dose-time analysis: A theoretical investigation. Radiother. Oncol. 40:259-270; 1996.
26. 26. Withers, H. R.; Taylor, J. M. C.; Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.